Novartis AG (NYSE:NVS)
| 100.93 Delayed Data As of Jun 09 |  +0.28 / +0.28%Today’s Change | 74.09 Today|||52-Week Range 105.56 | +11.25% Year-to-Date |
Latest NVS News | Press Releases
Today’s Trading
| Previous close | 100.65 |
| Today’s open | 100.32 |
| Day’s range | 99.68 - 101.02 |
| Volume | 3,168,391 |
| Average volume (3 months) | 2,174,499 |
| Market cap | $207.5B |
Data as of 3:59pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | -70.23% |
| Earnings growth (this year) | +10.80% |
| Earnings growth (next 5 years) | +5.10% |
| Revenue growth (last year) | -2.09% |
| P/E ratio | 31.0 |
| Price/Sales | 3.94 |
| Price/Book | 3.53 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | -0.12 | -0.31% |
| AZNAstraZeneca | -0.19 | -0.26% |
| ABBVAbbVie | +0.50 | +0.36% |
| NVONovo Nordisk | -1.38 | -0.87% |
Data as of 4:00pm ET, 06/09/2023
Financials
| Next reporting date | July 18, 2023 |
| EPS forecast (this quarter) | $1.69 |
| Annual revenue (last year) | $50.5B |
| Annual profit (last year) | $7.0B |
| Net profit margin | 13.76% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |
Forecasts
